GLSI stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Greenwich Lifesciences Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	4,573,190
Mar 31, 2026	4,632,642
Dec 31, 2025	4,632,642
Sep 30, 2025	10,102,403
Jun 30, 2025	9,152,711
Mar 31, 2025	8,203,019
Dec 31, 2024	7,253,327
Sep 30, 2024	2,378,088
Jun 30, 2024	2,378,088
Mar 31, 2024	2,378,088
Dec 31, 2023	2,378,088
Sep 30, 2023	2,378,088
Jun 30, 2023	2,543,139
Mar 31, 2023	2,173,120
Dec 31, 2022	1,743,865
Sep 30, 2022	1,314,772
Jun 30, 2022	720,250
Mar 31, 2022	660,798
Dec 31, 2021	660,582
Sep 30, 2021	660,204
Jun 30, 2021	660,204
Mar 31, 2021	669,096
Dec 31, 2020	677,988
Sep 30, 2020	707,880
Jun 30, 2020	542,829
Mar 31, 2020	368,886
Dec 31, 2019	194,943